Basic Information
LncRNA/CircRNA Name | circ_0016760 |
Synonyms | |
Region | |
Ensemble | |
Refseq |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | non small cell lung cancer |
ICD-0-3 | C34 |
Methods | qPCR, western blot, other |
Sample | NSCLC tissues and cell lines (A549, H358, H1299,and H1975) |
Expression Pattern | up-regulated |
Function Description | We found that circ_0016760 was enhanced in NSCLC tissues and cells and the upregulation of circ_0016760 is associated with advanced TNM stages, lymph node metastasis and adverse prognosis in NSCLC patients. Moreover, circ_0016760 could significantly promote cell growth and metastatic properties and inhibit cell apoptosis in NSCLC cells. In mechanism, circ_0016760 functioned as a sponge for miR-1287 and regulated the expression of GAGE1. Subsequently, functional assays illustrated that the oncogenic properties of circ_0016760 is partly attribute to the regulation of miR-1287/GAGE1 axis. |
Pubmed ID | 30103946 |
Year | 2018 |
Title | Upregulated Circular RNA circ_0016760 Indicates Unfavorable Prognosis in NSCLC and Promotes Cell Progression Through miR-1287/GAGE1 Axis |
External Links
Links for circ_0016760 | GenBank HGNC NONCODE |
Links for non small cell lung cancer | OMIM COSMIC |